课题基金 / 基金详情

Developmental Activities

Developmental Activities
发展活动
批准号:
7983887
负责人:
CHAD A. MIRKIN
金额:
$13.55万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2015-07-31

项目摘要

项目成果

CHAD A. MIRKIN的其他基金

相似基金

相关文献

中文摘要
翻译
拟议的国立大学- ccne的发展活动将包括三个组成部分:试点项目;
英文摘要
Developmental activities at the proposed NU-CCNE will include three components: Pilot Projects, Alliance Challenge Projects, and trans-Alliance activities. The current NU-CCNE has provided funding for pilot projects each year since its inception in 2005, and this program has been shown to be of critical importance in encouraging new and innovative ideas that will push the envelope ofthe current research and have potential to significantly enhance and advance research goals. Previously funded pilot projects have laid the groundwork for important new efforts and/or have been incorporated into the existing CCNE research portfolio. The new NU-CCNE will fund in-Center Pilot Projects, and proposes to expand this mechanism to inter-Alliance projects. These proposals will involve other Centers and Platforms across the Alliance network through synergistic projects that have the capacity to rapidly develop and advance technologies to the clinic by sharing the unique resources and strengths of the NU-CCNE. Finally, we will continue to contribute to trans-Alliance activities in order to build the Alliance community and encourage synergism by establishing a Bioinformatics Core to ensure information and data sharing, by participating in and assisting with the bulletins, and CCNE operation manuals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
  • 批准号:
    10539146
  • 项目类别:
  • 资助金额:
    $44.35万
  • 财政年份:
    2022
  • 负责人:
    CHAD A. MIRKIN
  • 依托单位:
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
  • 批准号:
    10709540
  • 项目类别:
  • 资助金额:
    $42.56万
  • 财政年份:
    2022
  • 负责人:
    CHAD A. MIRKIN
  • 依托单位:
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
  • 批准号:
    10402178
  • 项目类别:
  • 资助金额:
    $52.19万
  • 财政年份:
    2022
  • 负责人:
    CHAD A. MIRKIN
  • 依托单位:
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
  • 批准号:
    10591545
  • 项目类别:
  • 资助金额:
    $50.89万
  • 财政年份:
    2022
  • 负责人:
    CHAD A. MIRKIN
  • 依托单位:
海外基金